Charly R. Good

University City Science Center — United States

Medicine · Health Sciences

11h-index1.3kcitations69works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(35), Genetic factors in colorectal cancer(14), Epigenetics and DNA Methylation(13), RNA modifications and cancer(9), Immune Cell Function and Interaction(5)

Publications69 total

Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer
Cell Reports Medicine·2025· 2 citedOpen Access
Chromatin repression by PRC2 results in reduced gene expression driving key features of CD8 T cell exhaustion
The Journal of Immunology·2025
Deciphering the role of histone modifications in memory and exhausted CD8 T cells
Scientific Reports·2025· 4 citedOpen Access
Deciphering the role of histone modifications in memory and exhausted CD8 T cells
2025Open Access
237 Enhancing mesothelin-directed CAR T cell therapy for unresectable or metastatic pancreatic adenocarcinoma
Regular and Young Investigator Award Abstracts·2024· 1 citedOpen Access
Histone acetylation in an Alzheimer’s disease cell model promotes homeostatic amyloid-reducing pathways
Acta Neuropathologica Communications·2024· 17 citedOpen Access
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells
Immunity·2023· 151 citedOpen Access
Histone acetylation in an Alzheimer’s disease cell model promotes homeostatic amyloid-reducing pathways
2023Open Access
TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cells
Science Advances·2023· 25 citedOpen Access
Supplementary Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
2023Open Access
Supplementary Figure from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
2023Open Access
Supplementary Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
2023Open Access
Supplementary Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
2023Open Access
Supplementary Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
2023Open Access
Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
2023Open Access
Supplementary Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
2023Open Access
Supplementary Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
2023Open Access
Supplementary Figure from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
2023Open Access
Supplementary Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
2023Open Access
Supplementary Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Shelley L. Berger(40), Carl H. June(27), Sangya Agarwal(26), Shunichiro Kuramitsu(25), Marco Ruella(25), Nathan Singh(24), Pranali Ravikumar(23), Olga Shestova(22), Katharina E. Hayer(22), Seok Jae Hong(22), Elena J. Orlando(22), Karen Thudium Mueller(22), Ophir Shalem(22), Matthew D. Weitzman(22), Stephan A. Grupp(22), Saar Gill(22), Yong Gu Lee(21), Xueqing Maggie Lu(21), Raymone Pajarillo(21), Noelle V. Frey(21)